Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Documented concern — monitor and disclose
Clinically relevant documented concern. Disclose the supplement to your clinician and keep monitoring in place.
Mechanism and evidence
Statin plus high-dose niacin raises myopathy and hepatotoxicity risk; the large outcome trials that combined them did so under lipid-specialist supervision with lab monitoring.
Evidence tier: pharmacology-standard
No single PMID anchors this pair: the grading rests on established pharmacology (label practice and clinical standard) as agreed with the reviewer.
What to discuss with your prescriber
- High-dose niacin with a statin only under specialist supervision.
- New muscle pain or weakness while on both is a call-your-doctor symptom.